聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 2 分钟 46 秒 前

Merrimack Pharmaceuticals Announces MM-398 Achieves Primary Endpoint of Overall Survival in Phase 3 Trial in Post-Gemcitabine Metastatic Pancreatic Cancer

周四, 05/01/2014 - 12:45
MM-398 in combination with 5-fluorouracil and leucovorin demonstrates statistically significant advantage compared to control arm Plan to submit New Drug Application in 2014 Conference Call Scheduled for 8:30 a.m. ET Today CAMBRIDGE, Mass., May 1...
Biopharmaceuticals, Oncology
Merrimack Pharmaceuticals, MM-398, NAPOLI-1 study, metastatic pancreatic cancer

BOTOX(R) (Botulinum Toxin Type A) Receives a Positive Opinion in Fourteen European Countries for the Treatment of Focal Spasticity of the Ankle in Adult Post Stroke Patients

周四, 05/01/2014 - 12:38
This Positive Opinion Paves the Way for a Second Indication for BOTOX® in Adult Spasticity Associated with Stroke MARLOW, England, May 1, 2014 -- (Healthcare Sales & Marketing Network) --Today, Allergan Inc. announced that BOTOX® has received a...
Biopharmaceuticals, Regulatory
Allergan, BOTOX, Adult Spasticity, limb spasticity, stroke

Ivera Medical Announces Patent Decision From San Diego Court

周四, 05/01/2014 - 12:27
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Ivera Medical Corporation, headquartered in San Diego, CA, announced that the United States District Court for the Southern District of California has rendered summary judgment against some Ivera pate...
Devices, Litigation
Ivera Medical, Excelsior Medical, Hospira, Catheter Connections, Curos Tips

Ivera Launches New Tips in Response to Court Decision

周四, 05/01/2014 - 12:22
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Ivera Medical announced further detail behind its soon-to-be-released new Tips products, which the company announced earlier this month. The new product was developed after a Salt Lake City court rule...
Devices, Litigation
Ivera Medical, Catheter Connections, Curos Tips

Enterome Raises €10 million in Series B Fund Raising

周四, 05/01/2014 - 12:17
PARIS, May 1, 2014 -- (Healthcare Sales & Marketing Network) --ENTEROME Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, is pleased to announce that it has raised €...
Biopharmaceuticals, Venture Capital
Enterome Bioscience, gut microbiome, Metagenotyping

Elekta: Niklas Savander assumes role as Elekta’s new President and CEO

周四, 05/01/2014 - 12:12
STOCKHOLM--(Healthcare Sales & Marketing Network)--As announced in October 2013, Niklas Savander will today assume the role as Elekta’s President and CEO, succeeding Tomas Puusepp who will continue as member of the company’s Board of Directors. Niklas S...
Devices, Personnel
Elekta

Boston Scientific Launches Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System In Japan

周四, 05/01/2014 - 12:07
NATICK, Mass., May 1, 2014 -- (Healthcare Sales & Marketing Network) -- Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (BSX) has launched the Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary S...
Devices, Interventional Cardiology
Boston Scientific, Promus PREMIER, Everolimus, drug eluting stent

Abbott's First-of-Its-Kind MitraClip(R) Device Now Approved in Canada

周三, 04/30/2014 - 13:05
Treatment with Minimally Invasive Device Can Improve Symptoms, Disease Progression and Quality of Life for People with Mitral Valve Disease Who Are Too High Risk for Surgery MONTREAL ,(Healthcare Sales & Marketing Network) - Abbott today announced that ...
Devices, Interventional Cardiology, Regulatory
Abbott, MitraClip, mitral regurgitation

Teleflex partners with Intuitive Surgical to create access solutions for new da Vinci(R) Xi(TM) Surgical System

周三, 04/30/2014 - 12:56
WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has partnered with Intuitive Surgical to manufacture Weck® disposable trocar seals and obturato...
Devices, Surgery
Teleflex, Intuitive Surgical, da Vinci, Weck Vista, robotic surgery

InspireMD Announces Voluntary Field Action for MGuard(TM) Prime EPS

周三, 04/30/2014 - 12:46
BOSTON, April 30, 2014 -- (Healthcare Sales & Marketing Network) -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems (EPS), today announced that it has initiated a Voluntary Field ...
Devices, Interventional
InspireMD, Voluntary Field Action, MGuard , Prime EPS stent

FDA Approves New Liquid Form Of Treatment For Patients With Acute Lymphoblastic Leukemia (ALL) As Part Of A Combination Regimen

周三, 04/30/2014 - 12:37
PURIXAN™ (mercaptopurine) Oral Suspension Finally Makes Accurate Dosing Simple for Healthcare Professionals to Achieve--Especially with Children FRANKLIN, Tenn., April 30, 2014 -- (Healthcare Sales & Marketing Network) -- Rare Disease Therapeutics, Inc...
Biopharmaceuticals, Oncology, FDA
Rare Disease Therapeutics, PURIXAN, mercaptopurine, Acute Lymphoblastic Leukemia

Otsuka Wins European Marketing Authorization for Deltyba(TM) (delamanid)

周三, 04/30/2014 - 12:09
First grant of a marketing authorization of Otsuka’s novel drug for multidrug-resistant tuberculosis (MDR-TB) Deltyba is a new treatment option for MDR-TB. Globally, only half of MDR-TB cases experience successful outcomes, which leads to 170,000 deaths...
Biopharmaceuticals, Regulatory
Otsuka Pharmaceutical, Deltyba, delamanid, tuberculosis

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong